ArticleThe oncologist2025

Patient-reported continued benefits of pexidartinib for tenosynovial giant cell tumor based on a real-world study in the United States.

Dong Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.